Claim OwnershipMedscape Diabetes & Endocrinology Podcast
Subscribed: 588Played: 2,640
Subscribe
© Copyright 2018, Medscape
Description
Latest medical news and features from Medscape Diabetes & Endocrinology
68 Episodes
Reverse
1The ACP reviewed relevant studies but came to conclusions 'not germane to the way we treat patients with type 2 diabetes today,' says Dr Anne Peters.
Dr Kuchay discusses his findings from the E-LIFT study.
A new Medicare benefit can help patients prevent diabetes and improve other aspects of their health, says Dr Anne Peters.
Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.
Drs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to 'be aware.'
Dr JoAnn Manson offers clinicians a new resource to guide discussions with patients about vitamins and supplements.
An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.
Dr Alan Jacobs reports on a recent study suggesting that antihypertensive therapy might not return microcirculation to normal.
Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.
Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause.
Dr Chodak reviews a 'provocative' study on the risk for prostate cancer in men receiving testosterone therapy for hypogonadism.
The new ACC/AHA guidelines for hypertension lowered the threshold for a diagnosis of hypertension. Are these changes justified?
What are the key changes in the 2018 ADA Abridged Standards for Diabetes Care that primary care clinicians should know?
The American Heart Association sessions featured two new analyses from the FOURIER trial, which prompted a discussion on the cost-effectiveness of PCSK9 inhibitor lipid-lowering therapy.
Drs Yancy and O'Gara discuss the new definition of hypertension and when clinical judgment will come into play.
A new program cuts the risk of prediabetes progressing to type 2 diabetes by nearly 60%.
Dr Walton-Shirley reviews the key updates in the 2017 ACC/AHA guidelines for the Prevention, Detection, Evaluation and Management of High Blood Pressure with the guideline chair.
The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
Dr JoAnn Manson comments on a recent study revealing that gestational diabetes is like a window into a woman's future risk for cardiovascular disease and type 2 diabetes.
Comments
Download from Google Play
Download from App Store
United States